Soiza, Roy LScicluna, ChiaraThomson, Emma C.2021-12-022021-12-022021-03-01Soiza, R L, Scicluna, C & Thomson, E C 2021, 'Efficacy and safety of COVID-19 vaccines in older people', Age and Ageing, vol. 50, no. 2, afaa274, pp. 279–283. https://doi.org/10.1093/ageing/afaa2740002-0729ORCID: /0000-0002-1397-4272/work/84977585PubMedCentral: PMC7799251unpaywall: 10.1093/ageing/afaa274https://hdl.handle.net/2164/17611Declaration of Conflicts of Interest R.L.S. is a principal investigator in the Novavax COVID-19 vaccine trial. C.S. is a sub-investigator in the Novavax COVID-19 vaccine trial. E.C.T. has no conflicts of interest to declare. Views expressed are the authors’ own.5118293engSDG 3 - Good Health and Well-beingcoronavirusSARS-Cov-2elderlygeriatricsvaccinesHumansTreatment OutcomeFrail ElderlyPatient SelectionSARS-CoV-2COVID-19/epidemiologyPatient SafetyAgedCOVID-19 Vaccines/adverse effectsImmunization Programs/methodsGeriatrics/methodsR MedicineRJournal article10.1093/ageing/afaa274http://www.scopus.com/inward/record.url?scp=85102657992&partnerID=8YFLogxK502